Search research articles
Contact Us
Filters
Showing results (291-300 of 539) with videos related to
Page
of 54
Sort By:
International Journal of Cancer
|
March 21, 2008
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma
Jens Hillengass, Christian M Zechmann, Andreas Nadler, et al.
The FEBS Journal
|
April 25, 2023
Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma
Natalie Berghaus, Sarah Schreiner, Alexandra M Poos, et al.
Blood Advances
|
May 21, 2020
Search for multiple myeloma risk factors using Mendelian randomization
Molly Went, Alex J Cornish, Philip J Law, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up
Bo Björkstrand, Simona Iacobelli, Ute Hegenbart, et al.
Oncotarget
|
November 22, 2017
Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial
Michael Schmitt, Angela G Hückelhoven, Michael Hundemer, et al.
Blood Cancer Journal
|
August 20, 2024
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance
Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, et al.
Blood Cancer Journal
|
April 10, 2019
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial
Katja C Weisel, Christof Scheid, Manola Zago, et al.
Oncogene
|
March 1, 2005
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells
Karène Mahtouk, Dirk Hose, Thierry Rème, et al.
The Lancet. Oncology
|
September 25, 2010
Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
Annemiek Broyl, Sophie L Corthals, Joost Lm Jongen, et al.
Plos One
|
May 30, 2013
Cytotoxicity of tumor antigen specific human T cells is unimpaired by arginine depletion
Markus Munder, Melanie Engelhardt, Diana Knies, et al.
Page
of 54
Search research articles
Search
Showing results (291-300 of 539) with videos related to
Sort By:
Page
of 54
International Journal of Cancer
|
March 21, 2008
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma
Jens Hillengass, Christian M Zechmann, Andreas Nadler, et al.
The FEBS Journal
|
April 25, 2023
Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma
Natalie Berghaus, Sarah Schreiner, Alexandra M Poos, et al.
Blood Advances
|
May 21, 2020
Search for multiple myeloma risk factors using Mendelian randomization
Molly Went, Alex J Cornish, Philip J Law, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up
Bo Björkstrand, Simona Iacobelli, Ute Hegenbart, et al.
Oncotarget
|
November 22, 2017
Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial
Michael Schmitt, Angela G Hückelhoven, Michael Hundemer, et al.
Blood Cancer Journal
|
August 20, 2024
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance
Hauke Thomsen, Subhayan Chattopadhyay, Niels Weinhold, et al.
Blood Cancer Journal
|
April 10, 2019
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial
Katja C Weisel, Christof Scheid, Manola Zago, et al.
Oncogene
|
March 1, 2005
Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells
Karène Mahtouk, Dirk Hose, Thierry Rème, et al.
The Lancet. Oncology
|
September 25, 2010
Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial
Annemiek Broyl, Sophie L Corthals, Joost Lm Jongen, et al.
Plos One
|
May 30, 2013
Cytotoxicity of tumor antigen specific human T cells is unimpaired by arginine depletion
Markus Munder, Melanie Engelhardt, Diana Knies, et al.
Page
of 54